Intervention to Delay the Onset of Diabetes Mellitus in Very Young Siblings of Children with Type 1 Diabetes Mellitus

Articles in the same Issue

1. TABLE OF CONTENTS
2. Foreword
3. Introduction: The History and Impact of the International Beilinson Symposia
4. Disease-associated Autoantibodies as Predictive Markers of Type 1 Diabetes Mellitus in Siblings of Affected Children
5. Familial Predisposition of Type 1 Diabetes Mellitus in Japan, a Country with Low Incidence
6. Celiac Disease and its Link to Type 1 Diabetes Mellitus
7. Type 1 Diabetes Mellitus, Celiac Disease and their Association - Lessons from Antibodies
8. Diagnosis of MODY in the Offspring of Parents with Insulin-dependent and Non-insulin-dependent Diabetes Mellitus
9. Update on Major Trials for the Prevention of Type I Diabetes Mellitus: The American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT)
10. Intervention to Delay the Onset of Diabetes Mellitus in Very Young Siblings of Children with Type 1 Diabetes Mellitus
11. Changes in Food Habits in Families with a Newly Diagnosed Child with Type 1 Diabetes Mellitus
12. Psychological Aspects of Motherhood with Type 1 Diabetes Mellitus - A Personal Experience
13. Fathers of Children with Diabetes Mellitus and their Role in Coping Strategies in the Family
14. Children with Diabetes Mellitus and Family Functioning: Translating Research into Practice
15. Screening Programs to Identify Children At Risk for Diabetes Mellitus: Psychological Impact on Children and Parents
16. Early Life Stress and Disease among Offspring and Siblings of Individuals with Type I Diabetes Mellitus
17. Psychological and Ethical Aspects of Prevention Trials
18. Psychological Impact of Islet Cell Antibody Screening
19. School-age Children Born to Diabetic Mothers and to Mothers with Gestational Diabetes Exhibit a High Rate of Inattention and Fine and Gross Motor Impairment
20. Health Status of the Children of Diabetic Mothers
21. Children of Mothers with Diabetes Mellitus - A Comment
22. Epilogue: What Have We Learned to Improve the Treatment of Children with Diabetes Mellitus and their Families?